NSN 6505-01-539-5234
Part Details | TOBRAMYCIN INJECTION
6505-01-539-5234
Alternate Parts: NDC00703940204, NDC00703-9402-04, 060278, 06-0278, NDC63323030602, NDC63323-0306-02, NDC00703940204, NDC00703-9402-04, 6505-01-539-5234, 01-539-5234, 6505015395234, 015395234
| Supply Group (FSG) | NSN Assigned | NIIN | Item Name Code (INC) |
|---|---|---|---|
| 65 | APR 25, 2006 | 01-539-5234 | 66544 ( TOBRAMYCIN INJECTION ) |
REFERENCE DRAWINGS & PICTURES
Cross Reference | NSN 6505-01-539-5234
| Part Number | Cage Code | Manufacturer |
|---|---|---|
| NDC00703-9402-04 | 00E55 | CARDINAL HEALTH, INC.DBA CARDINAL HEALTH |
| 06-0278 | 89875 | DEFENSE LOGISTICS AGENCYDIRECTORATE OF MEDICAL MATERIEL |
| NDC63323-0306-02 | 57KZ6 | FRESENIUS KABI USA, LLC |
| NDC00703-9402-04 | 3V8D7 | TEVA PHARMACEUTICALS USA, INC. |
Technical Data | NSN 6505-01-539-5234
| Characteristic | Specifications |
|---|---|
| PRIMARY CONTAINER TYPE | VIAL |
| PRIMARY CONTAINER CONTENT QUANTITY | 2.000 MILLILITERS |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | CL40.000 MILLIGRAMS TOBRAMYCIN SULFATE |
| TOTAL PRIMARY CONTAINER QUANTITY | 25 |
| SPECIAL FEATURES | INDICATED FOR THE TREATMENT OF SERIOUS BACTERIAL INFECTIONS; 2ML VIALS; PKG/25 |
| AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER | 081202 |
| PROTECTIVE STORAGE FEATURE | CONTROLLED ROOM TEMPERATURE |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | TOBRAMYCIN INJ 40MG/ML 2ML VIALS 25S |
